The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate

Human Reproduction

Volumn 14, Issue 8, 1999, Pages 2054-2060

  Fraser, H M ^a   Dickson, S E ^a   Morris, K D ^a   Erickson, G F ^b   Lunn, S F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelial cells; Factor VIII; IGFBP 3; Monkey; Proliferation

Indexed keywords

ANGIOGENESIS INHIBITOR; BLOOD CLOTTING FACTOR 8; BROXURIDINE; FUMAGILLOL CHLOROACETYLCARBAMATE; PROGESTERONE; SOMATOMEDIN BINDING PROTEIN 3;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CORPUS LUTEUM; FEMALE; IN SITU HYBRIDIZATION; LUTEAL CELL; MACACA; MARMOSET; NONHUMAN; OVULATION; PROGESTERONE BLOOD LEVEL;

ANIMALIA; MACACA; MARMOSETS; PRIMATES;

EID: 0032780341     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.8.2054     Document Type: Article

References (23)

1. Abe, J., Zhou, W., Takuwa, N. et al. (1994) A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res., 54, 3407-3412.
2. Behrman, H.R., Endo, T., Aten. R.F. et al. (1993) Corpus luteum function and regression. Reprod. Med. Rev., 2, 153-180.
3. Christenson, L.K. and Stouffer, R. L. (1996) Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy. Endocrinology, 137, 367-374.
4. Cretton-Scott, E., Placidi, L., McClure, H. et al. (1996) Pharmacokinetics and metabolism of O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys. Cancer Chemother. Pharmacol., 38, 117-122.
5. Du Bois, D., and Du Bois, E.F. (1916) Clinical calorimetry X. A formula to estimate the approximate surface area if height and weight be known. Arch. Int. Med., 17, 863-871.
6. Dezube, B.J., Von Roenn, J.H., Holden-Wiltse, J. et al. (1998) Fumagillin analog in the treatment of Kaposi's sarcoma: a phase 1 AIDS clinical trial group study. AIDS clinical trial group no. 215 team. J. Clin. Oncol., 16, 1444-1449.
7. Duncan, W.C. Illingworth, P.J., Young, F.M. and Fraser, H.M. (1998) Induced luteolysis in the primate: rapid loss of luteinizing hormone receptors. Hum. Reprod., 13, 2532-2540.
8. Erickson, G.F., Natatani, A., Ling, N. et al. (1993) Insulin-like growth factor binding protein-3 gene expression is restricted to involuting corpora lutea in rat ovaries. Endocrinology, 133, 1147-1157.
9. Ferrara, N., Chen, H., Davis-Smyth, T. et al. (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med., 4, 336-340.
10. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1, 27-31.
11. Fraser, H.M. and Sandow, J. (1985) Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stump-tailed macaque monkey. J. Clin. Endocrinol. Melab., 60, 579-584.
12. Fraser, H.M., Lunn, S.F., Morris, K.D. et al. (1997) Initiation of high dose GnRH antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the LH surge. Hum. Reprod., 12, 101-106.
13. Fraser, H.M., Lunn, S.F., Kim, H. et al. (1998) Insulin-like growth factor binding protein-3 (IGFBP-3) mRNA in the endothelial cells of the primate corpus luteum. Hum. Reprod., 13, 2180-2185.
14. Fraser, H.M., Groome, N.P. and McNeilly, A.S. (1999) FSH-inhibin B interactions during the follicular phase of the primate menstrual cycle revealed by GnRH antagonist and anti-estrogen treatment. J. Clin. Endocrinol. Metab., 84, 1365-1369.
15. Gaytan, F., Morales, C., Bellido, C. et al. (1996) Proliferative activity in the different ovarian compartments in cycling rats estimated by the 5-bromodeoxyuridine technique. Biol. Reprod., 54, 1356-1365.
16. Jablonka-Shariff, A., Grazul-Bilska, A.T., Redmer, D.A. et al. (1993) Growth and cellular proliferation of ovine corpora lutea throughout the estrous cycle. Endocrinology, 133, 1871-1879.
17. Klauber, N., Rohan, R.M., Flynn, E. et al. (1997) Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nature Med., 3, 443-446.
18. Redmer, D.A. and Reynolds, L.P. (1996) Angiogenesis in the ovary. Rev. Reprod., 1, 182-192.
19. Rodger, F.E., Young, F.M., Fraser, H.M. et al. (1997) Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. Hum. Reprod., 12, 1723-1729.
20. Smith, K.B., Lunn, S.F. and Fraser, H.M. (1990) Inhibin secretion during the ovulatory cycle and pregnancy in the common marmoset monkey. J. Endocrinology, 126, 489-495.
21. Summers, P.M., Wennink, J. and Hodges, J.K. (1985) Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus). J. Reprod. Fertil., 73, 133-138.
22. Webley, G.E., Richardson, M.C., Smith, C.A. et al. (1990) Size distribution of luteal cells from pregnant and non-pregnant marmoset monkeys and a comparison of the morphology of marmoset luteal cells with those from the human corpus luteum. J. Reprod. Fertil., 90, 427-437.
23. Young, F.M., Illingworth, P.J., Lunn, S.F. et al. (1997) Cell death during luteal regression in the marmoset monkey (Callithrix jacchus). J. Reprod. Fertil., 111, 109-119.